Velarion Records
Free. Unsubscribe any time.

SUPERNUS PHARMACEUTICALS, INC. (SUPN)

SUPERNUS PHARMACEUTICALS, INC. filed 22 Form 4 statements naming a Rule 10b5-1 trading plan in the 2025 filing year, by 5 reporting owners, covering 36 transactions and 609,194 shares. None carries the SEC's AFF10B5ONE flag; all 22 name a plan in a footnote. 14 results prints are on file in the same window.

What stands out

Trades in SUPERNUS PHARMACEUTICALS, INC. 36

Adoption dates in SUPERNUS PHARMACEUTICALS, INC. 6

Results prints in SUPERNUS PHARMACEUTICALS, INC. 14

Trades before a print in SUPERNUS PHARMACEUTICALS, INC. 2

Interval to SUPERNUS PHARMACEUTICALS, INC.’s next reported results date

How the interval and sources are counted →

Adoption dates SUPERNUS PHARMACEUTICALS, INC. states

Filing text: “10b5-1 trading plan adopted March 3, 2025”

Reported results dates on file

A proxy statement is on file for this company in the same window, which is where a company states its own trading policy.

Other companies with plan records

Sources: SEC EDGAR full-text search and the SEC submissions API.